Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A first-in-human phase I study of the anticancer stem cell agent ipafricept (OMP-54F28), a decoy receptor for Wnt ligands, in patients with advanced solid tumors
Related Reading What Are The Genetic Factors In Nerve Compression Disorders And Effective Management Strategies Key Features Of Emotional Blindness And Effective Management Strategies Impact Of Renal Colic On Individuals And Effective Management Strategies Ro Wegovy Pricing and availability current as of June 2026
Why the Ipamorelin and Tesamorelin Blend Works: GHRH + GHRP Synergy Heres where the pharmacology gets exciting
Common side effects Most people experience mild to moderate side effects with GLP-1 medications like semaglutide and liraglutide
US$ 21.89
US$ 29.44
US$ 28.11
US$ 28.56
US$ 28.05
